RB1 and hepatocellular carcinoma: However, as mentioned above, the observation that activation of MYC and loss RB function are selected for in many cancers, including HCC [20], [21], [22], [26], would argue against the idea that activation of MYC is sufficient to inactivate RB function and that loss of both RB alleles is merely a passenger effect.